Press Releases

Here you will find a range of resources including press releases and updates on approved medications that we have contributed to, and information on our social media channels

Our latest press releases and resources for media

ACT News

Albuquerque Clinical Trials awarded Full Accreditation by the Association of the Accreditation of Human Research Protection Programs, Inc (AAHRPP)

Clinic Closures

January 2, 2024

New Year's Day Observed

January 15, 2024

Martin Luther King, Jr. Day

February 19, 2024

Presidents' Day

May 27, 2024

Memorial Day

July 4, 2024

Independence Day

September 2, 2024

Labor Day

November 28, 2024

Thanksgiving Day

November 29, 2024

Friday Following Thanksgiving

December 24, 2024

Christmas Eve - Half Day

December 25, 2024

Christmas Day

Sponsor News

Chronic Cough

Women's Health

Migraine Prevention

Cholesterol

Endometriosis

Pfizer’s ZAVZPRET™ (zavegepant) Migraine Nasal Spray Receives FDA Approval

Merck's Gefapixant (45 mg Twice Daily) Significantly Decreased Cough Frequency Compared to Placebo at Week 12 and 24 in Patients with Refractory or Unexplained Chronic Cough

Myovant Sciences and Pfizer Announce Collaboration to Develop and Commercialize Relugolix in Oncology and Women’s Health

FDA Approves QULIPTA™ (atogepant), the First and Only Oral CGRP Receptor Antagonist Specifically Developed for the Preventive Treatment of Migraine

FDA approves Novartis Leqvio® (inclisiran), first-in-class siRNA to lower cholesterol and keep it low with two doses a year

Myovant Sciences and Pfizer Receive U.S. FDA Approval of MYFEMBREE®, a Once-Daily Treatment for the Management of Moderate to Severe Pain Associated With Endometriosis

​